
Lance W. Rider
Examiner (ID: 18260, Phone: (571)270-1337 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 662 |
| Issued Applications | 191 |
| Pending Applications | 1 |
| Abandoned Applications | 470 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4514811
[patent_doc_number] => 07910561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-22
[patent_title] => 'Inhibitors of Akt activity'
[patent_app_type] => utility
[patent_app_number] => 11/792121
[patent_app_country] => US
[patent_app_date] => 2005-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34345
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/910/07910561.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792121
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792121 | Inhibitors of Akt activity | Dec 8, 2005 | Issued |
Array
(
[id] => 5648440
[patent_doc_number] => 20060134172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Agents which regulate, inhibit, or modulate the activity and/or expression of lysyl oxidase (LOX) and LOX-like proteases as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies'
[patent_app_type] => utility
[patent_app_number] => 11/293924
[patent_app_country] => US
[patent_app_date] => 2005-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3386
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134172.pdf
[firstpage_image] =>[orig_patent_app_number] => 11293924
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/293924 | Agents which regulate, inhibit, or modulate the activity and/or expression of lysyl oxidase (LOX) and LOX-like proteases as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies | Dec 4, 2005 | Abandoned |
Array
(
[id] => 5648439
[patent_doc_number] => 20060134171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Agents which regulate, inhibit, or modulate the activity and/or expression of formyl peptide receptors as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies'
[patent_app_type] => utility
[patent_app_number] => 11/292158
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4439
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134171.pdf
[firstpage_image] =>[orig_patent_app_number] => 11292158
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/292158 | Agents which regulate, inhibit, or modulate the activity and/or expression of formyl peptide receptors as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies | Nov 30, 2005 | Abandoned |
Array
(
[id] => 9868888
[patent_doc_number] => 08956656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-17
[patent_title] => 'Production of small particles'
[patent_app_type] => utility
[patent_app_number] => 11/284804
[patent_app_country] => US
[patent_app_date] => 2005-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 15657
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11284804
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/284804 | Production of small particles | Nov 21, 2005 | Issued |
Array
(
[id] => 5842080
[patent_doc_number] => 20060120965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Trimeric, macrocyclically substituted aminoisophthalic acid-halo-benzene derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/274895
[patent_app_country] => US
[patent_app_date] => 2005-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7184
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20060120965.pdf
[firstpage_image] =>[orig_patent_app_number] => 11274895
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/274895 | Trimeric, macrocyclically substituted aminoisophthalic acid-halo-benzene derivatives | Nov 15, 2005 | Abandoned |
Array
(
[id] => 5912249
[patent_doc_number] => 20060127311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Radiation dosimetry and blocking antibodies and methods and uses therefor in the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/282115
[patent_app_country] => US
[patent_app_date] => 2005-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16106
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127311.pdf
[firstpage_image] =>[orig_patent_app_number] => 11282115
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/282115 | Radiation dosimetry and blocking antibodies and methods and uses therefor in the treatment of cancer | Nov 15, 2005 | Abandoned |
Array
(
[id] => 5776267
[patent_doc_number] => 20060104907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Biologically potent analogues of the Dmt-Tic pharmacophore and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/280752
[patent_app_country] => US
[patent_app_date] => 2005-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9008
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20060104907.pdf
[firstpage_image] =>[orig_patent_app_number] => 11280752
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/280752 | Biologically potent analogues of the Dmt-Tic pharmacophore and methods of use | Nov 15, 2005 | Abandoned |
Array
(
[id] => 5638122
[patent_doc_number] => 20060069096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Pyrazolo[3,4-e]benzoxazoles for the treatment of glaucoma'
[patent_app_type] => utility
[patent_app_number] => 11/274437
[patent_app_country] => US
[patent_app_date] => 2005-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6911
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069096.pdf
[firstpage_image] =>[orig_patent_app_number] => 11274437
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/274437 | Pyrazolo[3,4-e]benzoxazoles for the treatment of glaucoma | Nov 14, 2005 | Abandoned |
Array
(
[id] => 5672169
[patent_doc_number] => 20060177523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Administration of a thiol-based chemoprotectant compound'
[patent_app_type] => utility
[patent_app_number] => 11/273723
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10577
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177523.pdf
[firstpage_image] =>[orig_patent_app_number] => 11273723
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/273723 | Administration of a thiol-based chemoprotectant compound | Nov 13, 2005 | Abandoned |
Array
(
[id] => 5727519
[patent_doc_number] => 20060058279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Topical compositions comprising ascomycins'
[patent_app_type] => utility
[patent_app_number] => 11/266639
[patent_app_country] => US
[patent_app_date] => 2005-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5071
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20060058279.pdf
[firstpage_image] =>[orig_patent_app_number] => 11266639
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/266639 | Topical compositions comprising ascomycins | Nov 2, 2005 | Abandoned |
Array
(
[id] => 5747519
[patent_doc_number] => 20060110450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Bilayer tablet of telmisartan and amlodipine'
[patent_app_type] => utility
[patent_app_number] => 11/265722
[patent_app_country] => US
[patent_app_date] => 2005-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5648
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20060110450.pdf
[firstpage_image] =>[orig_patent_app_number] => 11265722
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/265722 | Bilayer tablet of telmisartan and amlodipine | Nov 1, 2005 | Abandoned |
Array
(
[id] => 5807201
[patent_doc_number] => 20060093555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Imaging inflammatory conditions using superparamagnetic iron oxide agents'
[patent_app_type] => utility
[patent_app_number] => 11/263714
[patent_app_country] => US
[patent_app_date] => 2005-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13234
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20060093555.pdf
[firstpage_image] =>[orig_patent_app_number] => 11263714
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/263714 | Imaging inflammatory conditions using superparamagnetic iron oxide agents | Oct 31, 2005 | Abandoned |
Array
(
[id] => 5799398
[patent_doc_number] => 20060034892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Composition for topical administration'
[patent_app_type] => utility
[patent_app_number] => 11/258914
[patent_app_country] => US
[patent_app_date] => 2005-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6125
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034892.pdf
[firstpage_image] =>[orig_patent_app_number] => 11258914
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/258914 | Composition for topical administration | Oct 26, 2005 | Abandoned |
Array
(
[id] => 5850702
[patent_doc_number] => 20060233893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Aqueous solutions for the reduction of fatty tissue'
[patent_app_type] => utility
[patent_app_number] => 11/259757
[patent_app_country] => US
[patent_app_date] => 2005-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4101
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20060233893.pdf
[firstpage_image] =>[orig_patent_app_number] => 11259757
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/259757 | Aqueous solutions for the reduction of fatty tissue | Oct 26, 2005 | Abandoned |
Array
(
[id] => 5277893
[patent_doc_number] => 20090130025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'APPARATUS AND METHODS FOR THE PRODUCTION OF ULTRASOUND CONTRAST AGENTS'
[patent_app_type] => utility
[patent_app_number] => 11/577820
[patent_app_country] => US
[patent_app_date] => 2005-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5977
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20090130025.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577820
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577820 | APPARATUS AND METHODS FOR THE PRODUCTION OF ULTRASOUND CONTRAST AGENTS | Oct 24, 2005 | Abandoned |
Array
(
[id] => 5040643
[patent_doc_number] => 20070092925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Method of treating skin by delivering specific protein stabilizers/protectors to skin proteins and methods of selecting said stabilizers'
[patent_app_type] => utility
[patent_app_number] => 11/258257
[patent_app_country] => US
[patent_app_date] => 2005-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3885
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092925.pdf
[firstpage_image] =>[orig_patent_app_number] => 11258257
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/258257 | Method of treating skin by delivering specific protein stabilizers/protectors to skin proteins and methods of selecting said stabilizers | Oct 24, 2005 | Abandoned |
Array
(
[id] => 5748515
[patent_doc_number] => 20060111447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Inhibiting progressive cognitive impairment'
[patent_app_type] => utility
[patent_app_number] => 11/257287
[patent_app_country] => US
[patent_app_date] => 2005-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5195
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111447.pdf
[firstpage_image] =>[orig_patent_app_number] => 11257287
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/257287 | Inhibiting progressive cognitive impairment | Oct 23, 2005 | Abandoned |
Array
(
[id] => 9831500
[patent_doc_number] => 08940311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-27
[patent_title] => 'In situ controlled release drug delivery system'
[patent_app_type] => utility
[patent_app_number] => 11/256416
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9814
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11256416
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/256416 | In situ controlled release drug delivery system | Oct 20, 2005 | Issued |
Array
(
[id] => 5727539
[patent_doc_number] => 20060058300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Intermediates of bupropion metabolites synthesis'
[patent_app_type] => utility
[patent_app_number] => 11/253689
[patent_app_country] => US
[patent_app_date] => 2005-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18236
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20060058300.pdf
[firstpage_image] =>[orig_patent_app_number] => 11253689
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/253689 | Intermediates of bupropion metabolites synthesis | Oct 19, 2005 | Abandoned |
Array
(
[id] => 5710084
[patent_doc_number] => 20060051429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Pharmaceutical compositions and methods for managing skin conditions'
[patent_app_type] => utility
[patent_app_number] => 11/249496
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12482
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051429.pdf
[firstpage_image] =>[orig_patent_app_number] => 11249496
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/249496 | Pharmaceutical compositions and methods for managing skin conditions | Oct 13, 2005 | Abandoned |